Objective: Patients reported that a food product containing lactic acid improved their memory and thought processes. The ingredients of the tested food product are compound substances and smooth muscle fibre, the appropriate medium in which to analyse their effects. Acetylcholinesterase inhibitors are used to treat memory loss and failing thought performance. The aim of this study was to compare the effects of the lactic acid food product with the effects of acetylcholinesterase inhibitors.
Introduction
The clinical effects of the lactic acid food product (Kanne Brottrunk © GmbH & Co. Betriebsgesellschaft KG, Selm-Bork, Germany) have been described in a wide range of articles and publications. This lactic acid food product (LAF), which we have also examined in our research, is composed of compounds similar to that of different extracts and tinctures of plant origin. As is wellknown, compounds often have multiple effects on the organism.
In a randomised cohort study e.g., the LAF was used successfully as a prophylactic against colds and flu [1] . In an observational study with crossover design, the use of the LAF in treating noninsulin dependent diabetes mellitus resulted in a significant decrease in the HbA1c value [2] . Furthermore, two observational studies showed that, with the application of the LAF, the symptoms of psoriasis [3] and of hay fever [4] can be significantly reduced. As mentioned above, there is clinical evidence that the LAF improves memory and the thought processes [5] . ) , are all used therapeutically to suppress the effects of acetylcholine (ACh) [6] .
It was therefore also the aim of this study to examine whether substances which suppress the activity of acetylcholinesterase and butyrylcholinesterase are to be found in the LAF. Smooth muscle fibre is a suitable medium for impact analysis of biologically active substances, especially of multi-component mixtures, because it not only possesses almost all the receptors for hormones and mediators but also releases biologically active substances such as different forms of prostaglandins.
Original Research

Materials and methods
Substances
Food product containing lactic acid Table 1 shows an overview of the nutritional value of the tested LAF product. The inverstigations were carried out in the Institute for Food and Environment, Ahrensburg, Germany, in 2010 [7] .
Substances The smooth muscle fibres (SMF) of the guinea pig stomach (GPS) was incubated in a 20 ml organ bath with 50 and 100 µl of the LAF respectively for 20 min at 35ºC. The control samples were then incubated under the same conditions but without the addition of the LAF. Next, the SMF was homogenized in a Tris-HCl-buffer (5.10 -3 M EDTA, 10 -3 M ethylmaleimide, 1 M NaCl, 1% Triton X-100) in a ratio of 1:25 mg/ml buffer in an ice bath at 0ºC. The extent of acetylcholin-esterase activity was determined by the Ellman method using a Cary 1 spectrophotometer (Varian, Melbourne, VIC, Australia) [8] . 
Measurements of the spontaneous contractile activity of SMF and method of preparation
The measurements were performed according to the standardized Golenhofen method [9] . The SMF used in the experiments was taken from the stomach of a male guinea pig whose weight was approximately 300 g (HsdPoc:DH 300-349 g, Harlan Winkelmann GmbH, Borchen, Germany). All animal experiments were approved in advance by the Ruhr University Bochum commission responsible for animal research.
The muscle tissues had a length of between 12-14 mm and a width of between 1-2 mm and were taken from the corpus and antrum of the guinea pig stomach. Preparation of the muscle fibre was carried out in a circular direction, starting from the serosa along the greater curvature, running along the direction of the fibres.
The , 11.9; and glucose, 11.5.
Throughout the experiments the Krebs solution was aerated with carbogen gas. A pH factor within physiological limits of 7.2 to 7.4 (7.2 ± 0.8) was maintained. The organ baths of Krebs solution were kept at 35 ± 0.2ºC. It was measured under isometric conditions (mN).
Statistics
To take into account the specific variations and alterations of the spontaneous contractile activity (SCA) preparation's measured values, the doseresponse curves in each case of n = 10 individual experiments, always measured the excitation in percent (%) of maximal contractile activity of smooth muscle tissue when acted upon by 10 -5 M acetylcholine.
The processing of experimental data was performed by using the Statistica 4.5 (StatSoft Inc., Tulsa, OK, USA) program. For comparison between two groups, the t-Test (student) for unpaired samples was implemented. For comparisons between three or more groups, variance analysis (ANOVA) was used. The statistical comparisons were performed at the 5% significance level. The results are expressed as mean ± SD. In each case n = 7 measurements per experiment was performed.
Results
In Fig.1 , the effects of 50 µl LAF and 10 -5 M ACh are shown on the SCA of the SMF guinea pig stomach. The effect of 10 -5 M ACh shows the maximum contractile activity of the SMF. We see that what was achieved with 50 µl LAF (in 20 ml organ bath) was an activation of the SCA of the SMF of more than 50% of the maximal contractile activity of the SMF. Again in Fig.1 , we also see the effects of various concentrations of LAF on the SCA of the SMF and that the maximum stimulating effect attained at a concentration of 100 µl is about 80% of the maximum concentration of the SMF. Fig.2 shows the stimulating effects of LAF and 15 µl 10 -5 M ACh on the SCA of the SMF. Also in Fig.2 , the same effects with the addition of 10 -5 M atropine are shown. We see that with the prior suppression of the ACh receptors with atropine 10 -5 M, the stimulating effects of LAF are completely inhibited.
In our preliminary experiments with electrical field stimulation, we demonstrated that the stimulating effects of the LAF on the SCA of the SMF are most likely a consequence of the suppression of the AChE. Based on these considerations, we first examined the effects of the LAF on AChE activity and then followed by comparing the effects of galantamine (Nivalin In Fig.3 , the effects on the activity of the AChE of 10 µl LAF and 6.10 Table 2 shows the tabulated results shown in Figs.3&4. We see that the inhibitory effects of LAF on AChE activity are only 10% to 16% less than that of other AChE inhibitors.
In Fig.5 we see the results of the inhibitory effects on the activity of butyrylcholinesterase with the addition of 10 µl of LAF and 6.10 -6 M galantamine (Nivalin ® ). We see, that with the addition of LAF, the suppression of the activity of butyrylcholinesterase is more pronounced. The results for butyrylcholinesterase activity (Figs.5&6) are shown in Table 3 . It can be seen that the inhibitory effects are more with LAF although the differences amount to no more than about 16%.
Discussion
The results in Fig.1 show that LAF possesses very high biological activity. Even at concentrations as low as 50 µl/l, there is still a significant stimulating effect occurring in the SCA of the SMF of the guinea pig stomach. The maximum stimulating effects were registered at a concentration of 5 ml/l. The stimulating effects reach about 80% of maximum contractile activity of the SMF, which can be obtained with 10 -5 M ACh. The results shown in Fig.1 , demonstrates that for realization of the stimulating effects of LAF on the SCA sound structures of ACh receptors are required.
In case of inactivating the ACh receptors by use of 10 -5 M atropine, the stimulating effects of LAF will be suppressed up to 100%. Therefore we can assume, that there are two modes of actions of these stimulating effects of LAF on the SCA of the SMF. Either LAF contains substances which can show agonistic effects on the ACh receptors or there are substances which increase the level of ACh in the extracellular space by suppressing the activity of AChE.
Our assumption that the stimulating effects of LAF on the SCA of the SMF are a result of the suppression of AChE and have been confirmed by our present research. Our study of the comparative inhibitory effects of LAF, galantamine (Nivalin Table 2) on AChE showed that LAF produces a very pronounced inhibitory reaction on AChE, with a difference of a maximum of 16%. Butyrylcholine, which is found in the central nervous system, and it's suppression by LAF was more than 14% when compared to that of pyridostigmine bromide (Kalymin ® ). In light of these results further discussion must be promoted, in terms of clinical therapy, whether LAF can play a role as an AChE activity inhibitor. Only clinical studies can show whether and to what extent the in vitro effects of LAF have on clinical efficacy and in which stage of the disease. Moreover, it has to be proven whether LAF, in the future, can complement current esterase inhibitor treatment for senile dementia, degenerative diseases of the skeletal muscles and Alzheimer's.
